Microphthalmia & Nanophthalmos: Optical Correction of Extreme Axial Hyperopia (+10.00D to +20.00D) & Angle Closure Risks

In nanophthalmos (frequently linked to mutations in MFRP, TMEM98, or PRSS56), the crystalline lens is normal-sized or disproportionately large, but the vitreous cavity is compressed:

$$AL \in [15.0, 18.5\ \text{mm}] \implies F_{\text{refraction}} = \frac{n}{AL} - F_{\text{cornea+lens}} \approx \mathbf{+12.00\text{ to } +22.00\ \text{Diopters}}$$

Because the normal-sized lens occupies up to $30\%$ of the globe volume (compared to $4\%$ in normal adult eyes), the anterior chamber depth is critically shallow ($ACD < 2.0\ \text{mm}$), creating an extreme predisposition to pupillary block and angle-closure glaucoma.

Mounting a standard $+16.00\ \text{D}$ spherical lens into a frame yields a center thickness $>10\ \text{mm}$ and extreme mass, causing severe facial skin ulceration:

1. Freeform Atoric Surfacing: Uses individualized front and back aspheric profiles to flatten front base curve from $+14.00\ \text{D}$ down to $+8.00\ \text{D}$, eliminating peripheral spherical aberration.
2. High-Index 1.67 MR-7 or 1.60 MR-8: Reduces center thickness by $35\%\text{ to } 40\%$.
3. Minimal Frame Eye Size: Dispensing in eye sizes $\le 42\ \text{mm}$ cuts center thickness to under $5.2\ \text{mm}$.

Intraocular surgery in nanophthalmic eyes carries devastating risks of malignant glaucoma, massive choroidal effusion, and expulsive hemorrhage due to the rigid, non-compliant sclera. Non-invasive optical management with precision freeform spectacles and specialized scleral contact lenses is the absolute first-line clinical strategy.